NEW YORK (GenomeWeb) – Oxford Biodynamics announced today that it has signed a collaboration agreement with Holos Life Sciences to develop non-invasive epigenetic biomarkers linked to sports-related concussions.

Under the terms of the agreement, Holos will supply the participants' blood samples, while Oxford will provide its EpiSwitch platform and methodology for the development, evaluation, and validation of epigenetic biomarkers. The test's biomarker readouts will be based on minimally invasive blood testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.